Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T30085 | Target Info | |||
Target Name | Sodium/glucose cotransporter 2 (SGLT2) | ||||
Synonyms | Solute carrier family 5 member 2; Na(+)/glucose cotransporter 2; Low affinity sodium-glucose cotransporter | ||||
Target Type | Successful Target | ||||
Gene Name | SLC5A2 | ||||
Biochemical Class | Solute:sodium symporter | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Empagliflozin | Ligand Info | |||||
Structure Description | Structure of human SGLT2-MAP17 complex bound with empagliflozin | PDB:7VSI | ||||
Method | Electron microscopy | Resolution | 2.95 Å | Mutation | No | [1] |
PDB Sequence |
DNPADILVIA
30 AYFLLVIGVG40 LWSMCRTNRG50 TVGGYFLAGR60 SMVWWPVGAS70 LFASNIGSGH 80 FVGLAGTGAA90 SGLAVAGFEW100 NALFVVLLLG110 WLFAPVYLTA120 GVITMPQYLR 130 KRFGGRRIRL140 YLSVLSLFLY150 IFTKISVDMF160 SGAVFIQQAL170 GWNIYASVIA 180 LLGITMIYTV190 TGGLAALMYT200 DTVQTFVILG210 GACILMGYAF220 HEVGGYSGLF 230 DKYLGAATSL240 TVSEDPAVGN250 ISSFCYRPRP260 DSYHLLRHPV270 TGDLPWPALL 280 LGLTIVSGWY290 WCSDQVIVQR300 CLAGKSLTHI310 KAGCILCGYL320 KLTPMFLMVM 330 PGMISRILYP340 DEVACVVPEV350 CRRVCGTEVG360 CSNIAYPRLV370 VKLMPNGLRG 380 LMLAVMLAAL390 MSSLASIFNS400 SSTLFTMDIY410 TRLRPRAGDR420 ELLLVGRLWV 430 VFIVVVSVAW440 LPVVQAAQGG450 QLFDYIQAVS460 SYLAPPVSAV470 FVLALFVPRV 480 NEQGAFWGLI490 GGLLMGLARL500 IPEFSFGSGS510 CVQPSACPAF520 LCGVHYLYFA 530 IVLFFCSGLL540 TLTVSLCTAP550 IPRKHLHRLV560 FSLRHSKEER570 EDLDEDISED 646 PSWARVVNLN656 ALLMMAVAVF666 LWGFYA
|
|||||
|
ASN75
3.274
GLY79
4.021
HIS80
3.181
GLY83
3.564
LEU84
3.413
THR87
3.408
VAL95
3.319
PHE98
2.403
GLU99
3.242
ALA102
3.736
THR153
4.471
VAL157
3.728
LEU274
3.838
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural basis of inhibition of the human SGLT2-MAP17 glucose transporter. Nature. 2022 Jan;601(7892):280-284. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.